文献速递青光眼眼底病与葡萄膜炎

青光眼中OCT、OCTA与视野基于事件的进展检测比较

Event-Based Progression Detection Among OCT, OCT Angiography, and Visual Field in Glaucoma.
PubMed 文献 · JAMA Ophthalmol · 2026-01-01

本回顾性队列研究纳入116例患者180只眼,评估OCT、OCTA和视野在青光眼进展检测中的时序与一致性。结果显示OCTA血管密度检测进展最早,但特异性略低于OCT,提示OCTA在青光眼监测中可能具有互补作用。

要点

  • OCTA血管密度较视野提前2.3年检测到青光眼进展。
  • OCT CPRNFL厚度较视野提前1.5年检测到进展。
  • OCTA血管密度特异性68.9%,低于OCT CPRNFL厚度的75.6%。

核心结论

  • OCTA血管密度可能比OCT或视野更早检测到基于事件的青光眼进展,但特异性略低于OCT。
  • 研究结果支持OCTA在青光眼监测中具有潜在的互补作用。
  • 额外检测的成本效益有待进一步评估。

研究设计与样本

  • 回顾性队列研究,数据来自DIGS研究,设计于2024年8月。
  • 纳入2015年1月至2023年4月期间接受OCT、OCTA和视野检查的患者。
  • 要求随访至少2年且每种模态至少4次访视。
  • 共纳入116例患者(平均年龄67.6岁,女性61例占52.6%)的180只眼(111只视野前期,69只视野期)。

主要发现

  • 平均随访5.1年,107只眼(59.4%)被至少一种模态检测到进展。
  • OCTA血管密度检测到58只眼(32.2%)进展,OCT CPRNFL厚度检测到45只眼(25.0%),视野检测到59只眼(32.8%)。
  • 进展眼中,OCTA血管密度最早检测到进展40只眼(37.4%),OCT CPRNFL厚度32只眼(29.9%),视野26只眼(24.3%)。
  • 45只稳定眼中,OCT CPRNFL厚度特异性75.6%,OCTA血管密度特异性68.9%。
  • OCTA血管密度较视野进展平均提前2.3年(95%CI 1.3-3.2),OCT CPRNFL厚度较视野提前1.5年(95%CI 0.6-2.4),OCT CPRNFL厚度较OCTA血管密度提前0.2年(95%CI -0.6至0.9)。

关键数值与推荐

  • OCT和OCTA进展定义为连续2次访视变化超过重测变异性阈值。
  • 视野进展采用引导进展分析评估。

临床怎么用

  • 在青光眼监测中可考虑将OCTA作为补充检查,以更早发现进展。
  • 需权衡OCTA较早检测进展与特异性略低及额外检测成本之间的关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Early detection of glaucoma progression is essential. Optical coherence tomography angiography (OCTA) vascular metrics may identify progression before structural OCT or visual field changes. OBJECTIVE: To evaluate timing and agreement of event-based progression detection among OCT, OCTA, and visual field testing in glaucoma. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective cohort study designed in August 2024. Included were patients from the Diagnostic Innovations in Glaucoma Study (DIGS) who underwent OCT and OCTA imaging and visual field testing from January 2015 to April 2023. Inclusion required 2 or more years of follow-up and 4 or more visits with each modality. EXPOSURES: OCT, OCTA, and visual field testing. MAIN OUTCOMES AND MEASURES: OCT and OCTA progression were defined as change exceeding test-retest variability thresholds at 2 consecutive visits; visual field progression was assessed with guided progression analysis. Progression rates and lead times were compared. RESULTS: A total of 180 eyes (111 perimetric, 69 preperimetric) from 116 patients (mean [SD] age, 67.6 [13.7] years; 61 female [52.6%]) were included in this analysis. During mean (SD) follow-up of 5.1 (1.4) years, 107 eyes (59.4%) had progression detected by at least 1 modality as follows: 58 eyes (32.2%) by OCTA vessel density, 45 eyes (25.0%) by OCT circumpapillary retinal nerve fiber layer (CPRNFL) thickness, and 59 eyes (32.8%) by visual field testing. Among eyes with progression, the earliest detection occurred with OCTA vessel density in 40 eyes (37.4%), OCT CPRNFL thickness in 32 eyes (29.9%), and visual field testing in 26 eyes (24.3%). Among 45 stable eyes, specificity was 75.6% for OCT CPRNFL thickness and 68.9% for OCTA vessel density. Mean lead times were 2.3 years for OCTA vessel density before visual field progression (95% CI, 1.3-3.2 years), 1.5 years for OCT CPRNFL thickness before visual field progression (95% CI, 0.6-2.4 years), and 0.2 years for OCT CPRNFL thickness vs OCTA vessel density (95% CI, -0.6 to 0.9 years). CONCLUSIONS AND RELEVANCE: Results of this cohort study suggest that OCTA vessel density may detect event-based glaucoma progression earlier than OCT or visual field testing at the cost of a slight decrease in specificity compared with OCT. These findings support a potential complementary role for OCTA in glaucoma monitoring, although the cost-benefit of additional testing requires further evaluation.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Hashemi M, Nishida T, Moghimi S, et al. Event-Based Progression Detection Among OCT, OCT Angiography, and Visual Field in Glaucoma. JAMA Ophthalmol. 2026. PMID: 42690635. doi:10.1001/jamaophthalmol.2026.3545

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。